NCT05964387

Brief Summary

The purpose of this randomized, controlled clinical study is to evaluate if application of 38% SDF increases the efficacy of local anesthesia during operative dentistry on permanent molars affected by molar-incisor hypoplasia (MIH). The goal is to determine if pre-operative application of SDF results in improved local anesthesia and decrease in procedural pain in MIH affected teeth, thereby addressing an important challenge in routine clinical practice and contributing to the development of a treatment protocol for MIH affected molars.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
20mo left

Started Jun 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Jun 2023Dec 2027

Study Start

First participant enrolled

June 12, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 18, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

February 12, 2026

Status Verified

February 1, 2026

Enrollment Period

4.6 years

First QC Date

July 18, 2023

Last Update Submit

February 9, 2026

Conditions

Keywords

Silver diamine fluoride

Outcome Measures

Primary Outcomes (1)

  • Sixou and Barbosa-Rogier scale for local anesthesia efficacy

    Four point scale evaluating efficacy of local anesthesia

    At least two weeks following application of SDF or placebo on the enrolled tooth

Secondary Outcomes (1)

  • Schiff Cold Air Sensitivity Scale

    At least two weeks following application of SDF or placebo on the enrolled tooth

Other Outcomes (1)

  • Face, Legs, Activity, Cry, Consolability (FLACC) Scale

    At least two weeks following application of SDF or placebo on the enrolled tooth

Study Arms (2)

SDF

EXPERIMENTAL

38% SDF applied to hypomineralized permanent molar two weeks prior to restorative care of the tooth.

Device: SDF

Placebo

PLACEBO COMPARATOR

Inert liquid (colored water) applied to hypomineralized permanent molar two weeks prior to restorative care of the tooth.

Device: Placebo

Interventions

SDFDEVICE

38% SDF will be applied to the hypoplastic area of the enrolled first permanent molar.

SDF
PlaceboDEVICE

An inert liquid will be applied to the hypoplastic area of the enrolled first permanent molar.

Placebo

Eligibility Criteria

Age6 Years - 11 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • At least one hypomineralized first permanent molar with a primary cavitated caries lesion(s) or a cavitated tooth defect requiring restorative dental care with local anesthesia
  • American Society of Anesthesiologists (ASA) Physical Status Classification I or II (healthy children or those with mild systemic disease)
  • English speaking
  • Subjects for which basic behavior guidance (non-pharmacological or nitrous oxide/oxygen) is indicated

You may not qualify if:

  • Teeth with irreversible pulpitis and pulp necrosis
  • Patients requiring advanced behavior management such as moderate sedation, general anesthesia, and/or active or passive restraint
  • Inability of the child to cooperate due to special needs or other conditions
  • Allergy to SDF, local anesthetic or other material component
  • Subjects with ulcerative gingivitis or stomatitis
  • Subjects with known sensitivity to silver or other heavy-metal ions
  • Subjects showing abnormal skin sensitization in daily circumstances

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

RECRUITING

MeSH Terms

Conditions

Molar Hypomineralization

Condition Hierarchy (Ancestors)

Dental Enamel HypomineralizationDevelopmental Defects of EnamelTooth AbnormalitiesStomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • James Boynton, DDS

    University of Michigan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

James Boynton, DDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The subject, care provider/outcomes assessor, and investigator will be blinded to which arm the tooth is randomized.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Subjects randomized for application of 38% silver diamine fluoride or placebo on hypomineralized permanent molar two weeks before operative dentistry.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

July 18, 2023

First Posted

July 27, 2023

Study Start

June 12, 2023

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

February 12, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual Participant Data (IPD) is not planned to be shared.

Locations